Pre-hypertension and subclinical cardiac damage: A meta-analysis of echocardiographic studies

Cesare Cuspidi1, Carla Sala2, Marijana Tadic3

  • 1Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy; Istituto Auxologico Italiano, Milano, Italy.

Insights

Pre-hypertension (pre-HTN) is associated with intermediate cardiac changes between normal blood pressure and hypertension. These findings indicate pre-HTN is not benign and may benefit from early preventive strategies to avoid preclinical cardiac damage.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Imaging

Background:

  • The cardiac implications of pre-hypertension (pre-HTN) are not well-defined.
  • Subclinical cardiac damage in untreated pre-HTN requires further investigation.

Purpose of the Study:

  • To systematically analyze echocardiographic studies on pre-HTN.
  • To comprehensively assess structural and functional cardiac changes in pre-HTN.

Main Methods:

  • Systematic meta-analysis of 20 echocardiographic studies.
  • Inclusion of 73,556 subjects (normotensive, pre-HTN, and hypertensive).
  • Analysis of left ventricular mass, relative wall thickness, E/e' ratio, and left atrial size.

Main Results:

  • Pre-HTN subjects showed increased left ventricular mass index and relative wall thickness compared to normotensives.
  • Elevated E/e' ratio and left atrial diameter were observed in pre-HTN versus normotensive individuals.
  • Hypertensive subjects exhibited more pronounced cardiac alterations than pre-HTN subjects.

Conclusions:

  • Cardiac structural and functional alterations in pre-HTN are intermediate between normotensive and hypertensive states.
  • Pre-hypertension may not be a benign condition.
  • Early preventive strategies could mitigate preclinical cardiac damage in pre-HTN.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
585
Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K
pre-mRNA Processing02:01

pre-mRNA Processing

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
900
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
930